First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2015-03-16 01:05:15Open Document File Size: 41,46 KBShare Result on FacebookCompanyPierre Fabre Medicament Australia Pty Ltd / Generic Health Pty Ltd / Sandoz Pty Ltd / Activs Pty Ltd / Merck / The PBAC / Dr Reddy’s Laboratories (Australia) Pty Ltd / Aspen Pharma Pty Ltd / The Medical Oncology Group of Australia / Alphapharm Pty Ltd / Roche Products Pty Ltd / Apotex Pty Ltd / Fresenius Kabi Australia Pty Ltd / Dohme (Australia) Pty Ltd / Hospira Pty Ltd / /CountryAustralia / /EventBusiness Partnership / /IndustryTermunrestricted pharmaceutical benefits / Treatment of advanced or metastatic colorectal cancer / Treatment of hormone-dependent metastatic breast cancer / prevention of breast cancer / treatment of patients with rectal cancer / /MedicalConditionhormone-dependent metastatic breast cancer / cancer / breast cancer TOREMIFENE / oesophago-gastric cancer / tumour / metastatic colorectal cancer / Authority Required Advanced breast cancer / colon cancer / non-small cell lung cancer / Advanced breast cancer / breast cancer / anthracycline Authority Required Advanced breast cancer / rectal cancer / /MedicalTreatmentchemotherapy / /OrganizationWorld Health Organization / Private Hospital / Public Hospital / /PositionPrivate / /ProductTOREMIFENE tablet / cisplatin / Fareston / Megace / paclitaxel / Navelbine / Xeloda / MEGESTROL tablet / CAPECITABIINE tablets / /Technologychemotherapy / /SocialTag |